BackgroundCheck.run
Search For

Patricia S Greenhalgh, 62349 Nashawtuc Rd, West Concord, MA 01742

Known as:
Patricia Higgins Patr Greenhalgh Trish Greenhalgh
Related to:
Jennifer S Greenhalgh

Patricia Greenhalgh Phones & Addresses

349 Nashawtuc Rd, Concord, MA 01742    617-2710576   

311 Woodland Way, North Chatham, MA 02650    508-3481413   

7 Fieldstone Ter, Brewster, MA 02631    508-8963038   

5 Balsam Dr, Bedford, MA 01730    781-2710576   

Cambridge, MA   

Brookline, MA   

5 Balsam Dr, Bedford, MA 01730    339-9274730   

Work

Position: Professional/Technical

Education

Degree: Graduate or professional degree

Emails

p***[email protected]
Get Report
Control this profile

Mentions for Patricia S Greenhalgh

Publications & IP owners

Us Patents

Modified Cea Nucleic Acid And Expression Vectors

US Patent:
7786278, Aug 31, 2010
Filed:
Apr 9, 2003
Appl. No.:
10/510677
Inventors:
Mark Parrington - Bradford, CA
Linong Zhang - Concord, CA
Benjamin Rovinski - Thornhill, CA
Linda R. Gritz - Somerville MA, US
Patricia Greenhalgh - Bedford MA, US
International Classification:
C07H 21/02
US Classification:
536 231
Abstract:
The present invention relates to a nucleic acid encoding a polypeptide and the use of the nucleic acid or polypeptide in preventing and/or treating cancer. The invention relates to improved vectors for the insertion and expression of foreign genes encoding tumor antigens for use in immunotherapeutic treatment of cancer. One such foreign DNA sequence is modified CEA nucleic acid.

Modified Cea Nucleic Acid And Expression Vectors

US Patent:
8236776, Aug 7, 2012
Filed:
Mar 2, 2010
Appl. No.:
12/716239
Inventors:
Mark Parrington - Bradford, CA
Linong Zhang - Concord, CA
Benjamin Rovinski - Thornhill, CA
Linda R. Gritz - Somerville MA, US
Patricia Greenhalgh - Bedford MA, US
Assignee:
Sanofi Pasteur Limited - Toronto, Ontario
International Classification:
A61K 48/00
US Classification:
514 44R
Abstract:
The present invention relates to a nucleic acid encoding a polypeptide and the use of the nucleic acid or polypeptide in preventing and/or treating cancer. The invention relates to improved vectors for the insertion and expression of foreign genes encoding tumor antigens for use in immunotherapeutic treatment of cancer. One such foreign DNA sequence is modified CEA nucleic acid.

Modified Cea Nucleic Acid And Expression Vectors

US Patent:
8530442, Sep 10, 2013
Filed:
Jun 25, 2012
Appl. No.:
13/532035
Inventors:
Mark Parrington - Bradford, CA
Linong Zhang - Concord, CA
Benjamin Rovinski - Thornhill, CA
Linda R. Gritz - Somerville MA, US
Patricia Greenhalgh - Bedford MA, US
Assignee:
Sanofi Pasteur Limited - Toronto, Ontario
International Classification:
A61K 48/00
US Classification:
514 44R, 514 193
Abstract:
The present invention relates to a nucleic acid encoding a polypeptide and the use of the nucleic acid or polypeptide in preventing and/or treating cancer. The invention relates to improved vectors for the insertion and expression of foreign genes encoding tumor antigens for use in immunotherapeutic treatment of cancer. One such foreign DNA sequence is modified CEA nucleic acid.

Novel Insertion Sites In Pox Vectors

US Patent:
2006015, Jul 20, 2006
Filed:
Feb 20, 2004
Appl. No.:
10/543944
Inventors:
Dennis Panicali - Acton MA, US
Gail Mazzara - Winchester MA, US
Linda Gritz - Somerville MA, US
Patricia Greenhalgh - Bedford MA, US
International Classification:
A61K 39/275
C12N 7/00
C12N 15/86
US Classification:
424232100, 435456000, 435235100
Abstract:
The present invention provides novel insertion sites for introducing DNA into pox vectors.

Novel Insertion Sites In Pox Vectors

US Patent:
2010013, Jun 3, 2010
Filed:
Dec 16, 2009
Appl. No.:
12/639781
Inventors:
Dennis L. Panicali - Acton MA, US
Gail P. Mazzara - Winchester MA, US
Linda R. Gritz - Somerville MA, US
Patricia Greenhalgh - Bedford MA, US
Assignee:
The United States of America, as represented by the Secretary, Dept. of Health and Human Services - Bethesda MD
International Classification:
A61K 39/275
C12N 7/01
C12N 15/86
C12N 5/078
A61P 31/12
US Classification:
4242321, 4352351, 435456, 435372
Abstract:
The present invention provides novel insertion sites for introducing DNA into pox vectors.

A Method Of Determining Virus Removal From A Sample Containing A Target Protein Using Activated Carbon

US Patent:
2016012, May 5, 2016
Filed:
Apr 4, 2014
Appl. No.:
14/891727
Inventors:
- Billerica MA, US
Ushma MEHTA - Westford MA, US
Damon ASHER - Jefferson MA, US
Patricia GREENHALGH - Bedford MA, US
Assignee:
EMD MILLIPORE CORPORATION - Billerica MA
International Classification:
G01N 33/569
C12Q 1/06
Abstract:
The present invention provides methods for determining whether activated carbon can be used for removing viruses or a certain virus from a sample containing a target protein.

Isbn (Books And Publications)

Children And Youth: An Overview

Author:
Patricia Greenhalgh
ISBN #:
0133106403

Possible Relatives

Cynthia R Greenhalgh  David C Greenhalgh  Deborah A Greenhalgh  Dan L Greenhalgh  Daniel M Greenhalgh  Diane M Greenhalgh  Donald W Greenhalgh  Patricia M Johnson  Patricia M Stanard  Patricia B Standard 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.